リウマチ性心疾患における肺血量および,イソプロテレノールによる肺血量変化
Circulation
|January 1, 1963
まとめ
肺の血液量は,ミトラル狭窄症の患者で上昇しています. 左心房圧や脳卒中量などの要因は,この体積に影響を及ぼし,イソプロテレノールは,血管の伸縮性を高めることによって,これを増加させます.
科学分野:
- 心臓病学 心臓病学
- 肺循環 肺循環について
- ヘモダイナミクスは,
背景:
- 肺血量 (PBV) は重要な血液動力学的パラメータです.
- PBVの上昇は,様々な心血管疾患と関連しています.
研究 の 目的:
- 心臓病患者の肺血量測定のために.
- PBVと血液動力学的要因の関係を調査する.
- イソプロテレノールがPBVに及ぼす効果を評価する.
主な方法:
- 正常な被験者と心臓病患者の肺血量測定.
- 左心房圧,肺血管抵抗,脳卒中量とのPBVの多重相関分析.
- イソプロテレノールの投与とPBVと肺血管抵抗の測定.
主要な成果:
- 側頭筋狭窄症の患者は,正常な被験者と比較して,著しく高いPBVを示した.
- 左心房圧,肺血管抵抗,脳卒中量は,PBVと独立して相関していた.
- イソプロテレノールは,PBVを著しく増加させ,肺血管抵抗を低下させ,血管拡張性の増加を示唆した.
結論:
- ミトラス狭窄症は,肺血量増加と関連しています.
- 血液動力学的要因は,PBVの調節に重要な役割を果たします.
- PBVに対するイソプロテレノールの効果は,肺血管の伸縮性の増加を含む潜在的なメカニズムを示しています.
関連する概念動画
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...


